miR-223: An Immune Regulator in Infectious Disorders
MicroRNAs (miRNAs) are diminutive noncoding RNAs that can influence disease development and progression by post-transcriptionally regulating gene expression. The anti-inflammatory miRNA, miR-223, was first identified as a regulator of myelopoietic differentiation in 2003. This miR-223 exhibits multi...
Main Authors: | Shun Yuan, Qi Wu, Zhiwei Wang, Yanjia Che, Sihao Zheng, Yuanyang Chen, Xiaohan Zhong, Feng Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.781815/full |
Similar Items
-
Relevance of miR-223 as Potential Diagnostic and Prognostic Markers in Cancer
by: Faisal Aziz, et al.
Published: (2022-02-01) -
Overexpression of miR-223 Promotes Tolerogenic Properties of Dendritic Cells Involved in Heart Transplantation Tolerance by Targeting Irak1
by: Shun Yuan, et al.
Published: (2021-08-01) -
MiR-223 as a Regulator and Therapeutic Target in Liver Diseases
by: Jiarong Gu, et al.
Published: (2022-03-01) -
MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target
by: Meng-Wan Zhang, et al.
Published: (2021-01-01) -
Diagnostic value of plasma-derived exosomal miR-223 for epithelial ovarian cancer
by: Li Yang, et al.
Published: (2024-03-01)